EnLyte (Jaymac Pharmaceuticals LLC)
Welcome to the PulseAid listing for the EnLyte drug offered from Jaymac Pharmaceuticals LLC. This Methylating Activity [MoA],Methylating Agent [EPC],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Folate Analog [EPC],Folic Acid [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Jaymac Pharmaceuticals LLC |
| NON-PROPRIETARY NAME: | leucovorin, folic acid, levomefolate magnesium, ferrous cysteine glycinate, 1,2-docosahexanoyl-sn-glycero-3-phosphoserine calcium, 1,2-icosapentoyl-sn-glycero-3-phosphoserine calcium, phosphatidyl ser |
| SUBSTANCE NAME: | LEUCOVORIN; FOLIC ACID; LEVOMEFOLATE MAGNESIUM; FERROUS CYSTEINE GLYCINATE; 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; PHOSPHATIDYL SER |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Methylating Activity [MoA],Methylating Agent [EPC],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Folate Analog [EPC],Folic Acid [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, DELAYED RELEASE PELLETS |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2011-10-01 |
| END MARKETING DATE: | 0000-00-00 |
EnLyte HUMAN PRESCRIPTION DRUG Details:
| Item Description | EnLyte from Jaymac Pharmaceuticals LLC |
| LABELER NAME: | Jaymac Pharmaceuticals LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5; 1; 7; 13.6; 6.4; 800; 12; 25; 25; 25; 50; 25; 24; 1; 1; 500; 1.83; 3.67(mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; ug/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1) |
| START MARKETING DATE: | 2011-10-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64661-711_c8146638-0c20-4387-ac9e-aff5cbc991ae |
| PRODUCT NDC: | 64661-711 |
| APPLICATION NUMBER: | |
Other LEUCOVORIN; FOLIC ACID; LEVOMEFOLATE MAGNESIUM; FERROUS CYSTEINE GLYCINATE; 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; PHOSPHATIDYL SER Pharmaceutical Manufacturers / Labelers:
